Burning Rock Biotech’s second-quarter Revenue fell 9.3% to RMB134.7 million (US$19.9 million), while net loss rose to RMB18.4 million (US$2.7 million). For investors, the results show stronger in-hospital revenue alongside weaker central-laboratory and pharma services revenue, while the company points to Long-term Growth and new registration certificates.
Key Highlights
- Burning Rock’s in-hospital revenue increased 7.4% to RMB67.1 million, driven by higher sales volume.
- Gross Margin was 72.6%, compared with 72.8% in the same period of 2025.
- Pharma Research and Development revenue declined 31.8% to RMB30.8 million as testing services for customers decreased.
Revenue Shifts Across Channels
Net loss increased to RMB18.4 million (US$2.7 million) from RMB9.7 million. In-hospital revenue reached RMB67.1 million (US$9.9 million), rising 7.4% from RMB62.5 million in the same period of 2025. The increase was driven by higher sales volume. Central laboratory revenue fell 10.0% to RMB36.8 million (US$5.4 million) from RMB40.9 million. Burning (NASDAQ: BNR) Rock attributed the decline primarily to fewer tests as it continued shifting toward in-hospital business. Revenue from pharma research and development services decreased 31.8% to RMB30.8 million (US$4.6 million) from RMB45.1 million, mainly because fewer testing services were performed for pharma customers.
Gross Margin Was 72.6%
Gross margin was 72.6%, compared with 72.8%. Central laboratory gross margin was 85.7%, versus 87.9%, with the decrease primarily driven by increased depreciation. In-hospital gross margin rose to 77.1% from 74.4%, which Burning Rock attributed primarily to higher sales Volume of high-margin products. Pharma research and development services had a 47.2% gross margin, compared with 56.8%. The company said the decline was primarily related to lower testing volume for higher-margin projects. Operating expenses decreased 3.2%. Research and development expenses decreased 37.3%, while selling and Marketing expenses increased 22.7% and general and administrative expenses increased 19.2%.
Certificates Expected In Coming Quarters
The company also expects new registration certificates in the coming quarters. The company reported the second-quarter results on September 10, 2026.



Please wait processing your request...